MedPath

To Study Efficacy of Erandabhrista sunthi and Simhanad guggulu in the management of Amavata w.s.r. Rheumatoid arthritis

Not Applicable
Completed
Conditions
Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified
Registration Number
CTRI/2022/06/043316
Lead Sponsor
Government Akhandanand Ayurved College and Hospital Bhadra Ahmedabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.Patient willing to participate in this clinical trial.

2.Present with more indolent arthralgia before onset of clinically apparent joint swelling and low-grade fever.

3.Clinically Patient having sign and symptoms of Amavata.

Exclusion Criteria

1.Age- Below 18 years and above 60 years.

2.Patients having concomitant diseases like uncontrolled hypertension, HIV, malignancy, diabetes mellitus, etc.

3.Patient having any other acute or systemic illness

4.Chronicity of more than 10 years.

5.Patients who have developed joint deformities like Boutonniere deformity, Swan-neck deformity and Rheumatoid nodules, etc.

6.Patients diagnosed with Ayurveda diagnosis like Sandhivata, Sarvanga Vata etc. will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Result will be assessed by observing Clinical improvement in severity of signs & symptoms of Amavata given below <br/ ><br>1.Angamarda (Bodyache) <br/ ><br>2.Aruchi (Anorexia) <br/ ><br>3.Trushna (Polydipsia) <br/ ><br>4.Alasya (Lethargy) <br/ ><br>5.Gaurav (Heaviness of Body) <br/ ><br>6.Jvara (Fever) <br/ ><br>7.Apaka (Indigetion) <br/ ><br>8.Shunata (Joint swelling)Timepoint: 6 weeks
Secondary Outcome Measures
NameTimeMethod
Result will be assessed on the basis of vas scale assessment for pain.Timepoint: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath